Ben Liu

Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT).

Zhiquan Hu, F. Zhou, Peng-Yu Chen, 2022, European journal of cancer.

A phase II, multicenter, randomized, open-label study to evaluate the safety and tolerability of proxalutamide (GT0918) in subjects with metastatic castrate-resistant prostate cancer (mCRPC).

Zhiquan Hu, D. He, Yinghao Sun, 2021 .

Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

P. Zhang, Qing-jun Liu, D. Shang, 2022, Frontiers in Pharmacology.

Indications, strategies, and development on prostate targeted biopsy: Report of the Panjiayuan Consensus Conference 2022

N. Xu, Baojun Wang, Hongliang Shen, 2023, UroPrecision.

Proxalutamide in metastatic castration‐resistant prostate cancer: Primary analysis of a multicenter, randomized, open‐label, phase 2 trial

Zhiquan Hu, J. Hou, Dongwen Wang, 2023, International journal of cancer.

Relationship Between CD8+ T Cells and Prognosis of Esophageal Cancer Patients: A Systematic Review and Meta-analysis

Chao Gao, Zeyuan Liu, Ben Liu, 2023, Molecular biotechnology.

治疗良性前列腺增生的六种新微创手术

Ben Liu, Xinyang Niu, 2023, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences.